Patients on GLP-1 medications experience fat loss to varying degrees, and because cheek volume depends on both fat and collagen, that loss can make the face look flatter or more deflated faster than typical aging alone, says New York dermatologist Jane Yoo, MD
conducted target trial emulations comparing dual GLP-1/GIP agonists to GLP-1 monotherapy in patients with type 2 diabetes, finding that dual agonists were linked to numerically lower risks of MALOs, although confidence intervals overlapped, suggesting that extended observation period and larger patient cohorts may be needed to definitively establish comparative effectiveness [61]
Research Potential: Offers a valuable model for studying growth hormone-related therapies
Those with lower levels of folate are more likely to experience depression and less likely to respond to antidepressant medications
Take the Next Step Toward a Healthier Future If youve struggled with weight for years or feel stuck despite consistent effort, GLP-1 therapy may offer the support you need